China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ)

60.79 +0.88 (+1.47%) At close: 03:04PM CST

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Guanlan High-tech Park
No. 1, Guanqing Road Guanhu Street Longhua District
Shenzhen 518110
China
86 755 8336 0999
https://www.999.com.cn

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 20,318

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Zheng Liang	CFO & Financial Director	N/A	N/A	1979
Ms. Hui Zhou	VP, Secretary, General Counsel, Chief Compliance Officer & Director	N/A	N/A	1972
Mr. Liang Wang	Vice President	N/A	N/A	1980

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China.

Corporate Governance

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.